Co-authored by Brian Gross Readers of this blog may recall the September 2, 2011 post in which we reported on a federal lawsuit filed by several tobacco companies in the District of Columbia. The suit challenged new tobacco labeling restrictions imposed by the FDA after passage of the 2009 Family Smoking Prevention and Tobacco Control Act. As… Continue Reading
Monthly Archives: November 2011
Congress Boosts FDA’s Ability to Effectuate Food Safety Modernization Act
Posted in Foodborne Illness, Products LiabilityCo-authored by Brian Gross In our October 25, 2011 post, Food Safety Modernization Act: Did Congress Bite Off More Than It Can Chew? we expressed concern regarding the FDA’s ability to fully implement the Food Safety Modernization Act (“FSMA”) given its budgetary restrictions. As outlined in our prior post, FSMA provides for increased regulation and oversight… Continue Reading
The Pharmaceutical Balancing Act: What’s A Reasonable Side Effect For Prescription Medications
Posted in Litigation Trends, Pharmaceutical and Medical DevicesCo-authored by Brian Gross Earlier this month, an article on Slate.com relayed the results of a recent scientific study which identified a previously undocumented potential side effect associated with the use of statins. Statins are a widely popular type of medication used to control cholesterol levels which are taken by one in four Americans over the age… Continue Reading
Pennsylvania Supreme Court to Rule on Whether “Every Breath You Take” Theory Holds Water in Asbestos Litigation
Posted in Asbestos Litigation, Litigation TrendsCo-authored by Brian Gross The health hazards associated with asbestos have been documented, at least to some degree, for many years. Yet the litigation of asbestos injury claims is as robust and contentious as ever. Why? Well, much of it stems from the fact that there is controversy in the medical and scientific community as to… Continue Reading
Editor
Brian Gross
Brian D. Gross is a partner at Cooley Manion Jones who has extensive experience in a broad spectrum of litigation. He is also a member of several corporate defendants’ national trial teams. MoreContributors
Jonathan Tabasky
Jonathan Tabasky has defended product liability and toxic tort claims throughout New England. Jon represents an array of companies, including those that manufacture prescription drugs, protective clothing, fittings, heating devices, wire and cable, trucks, aircraft and turbines. More
Jason Cincilla
Jason Cincilla is a partner at Cooley Manion Jones and the lead attorney in the firm’s Delaware office. He conducts and supervises a broad litigation practice, and he has extensive experience in all stages of litigation in many areas. More
Michael R. Brown
Michael R. Brown is an associate in the Boston office of Cooley Manion Jones, where his practice focuses on commercial disputes and products liability actions. More
Carrie Lin
Carrie Lin is an associate in Cooley Manion Jones' San Francisco office. Her civil litigation practice focuses on tobacco and asbestos matters as well as the prosecution of employment class action matters. More
Eric Skelly
Eric Skelly is an associate with Cooley Manion Jones. He is a civil litigator who focuses his practice on all aspects of civil litigation including food liability matters, business and commercial disputes, products liability, and toxic torts. More
Margaret Moran
Margaret Moran is an associate with Cooley Manion Jones where her practice focuses on civil litigation, including products liability and complex torts litigation. More
Shaina Rasmussen
Shaina Rasmussen is an associate in Cooley Manion Jones’ Products Liability and Complex Tort Defense Practice Group. Prior to joining CMJ, Shaina worked as a Direct Claims Manager and Mass Tort and Environmental Litigation attorney. More
April Luna
April M. Luna is an associate in the firm’s Boston office. Her civil litigation practice focuses on toxic tort and products liability litigation. More
Subscribe to this blog via RSS
View Cooley Manion Jones' Linkedin Profile
Follow Us on Twitter